Personal information

Websites & social links

ResearchGate

Countries

United Kingdom

Activities

Collapse all

Employment (3)

University of Dundee: Dundee, GB

2023-01-04 to present | Statistician (Respiratory Research Group)
Employment
Source: Self-asserted source
Jon Stobo

University of Glasgow: Glasgow, Glasgow, GB

2018-08-01 to 2022-12-15 | Biostatistician (Cancer Research UK Clinical Trials Unit Glasgow)
Employment
Source: Self-asserted source
Jon Stobo

University of Glasgow: Glasgow, Glasgow, GB

2012-09-17 to 2018-08-01 | Junior Biostatistician (Cancer Research UK Clinical Trials Unit Glasgow)
Employment
Source: Self-asserted source
Jon Stobo

Education and qualifications (2)

University of Glasgow: Glasgow, Glasgow, GB

2011-09-15 to 2012-09-14 | MSc Statistics (with Merit) (School of Mathematics and Statistics)
Education
Source: Self-asserted source
Jon Stobo

University of Glasgow: Glasgow, Glasgow, GB

2005-09-01 to 2009-06-01 | BSc Applied Mathematics (School of Mathematics and Statistics)
Education
Source: Self-asserted source
Jon Stobo

Works (14)

Concurrent Olaparib and Radiation Therapy in Older Patients With Newly Diagnosed Glioblastoma: The Phase 1 Dose-Escalation PARADIGM Trial

International Journal of Radiation Oncology*Biology*Physics
2024-01-08 | Journal article
DOI: 10.1016/j.ijrobp.2024.01.011
Part of ISSN: 0360-3016
Contributors: Sarah Derby; Mark R. Jackson; Karin Williams; Jamie Stobo; Caroline Kelly; Lorna Sweeting; Shumaila Shad; Christopher Herbert; Susan C. Short; Aoife Williamson et al.
Source: Self-asserted source
Jon Stobo

Inflammatory and mucociliary dysfunction based endotypes across the spectrum of chronic airways diseases

Respiratory infections and bronchiectasis
2023-09-09 | Conference abstract
DOI: 10.1183/13993003.congress-2023.pa2827
Contributors: Erin Cant; Mathieu Bottier; Morven Shuttleworth; Jamie Stobo; Lidia Perea; Alison Dicker; Holly R Keir; Megan L Crichton; Jeffrey Huang; Amelia Shoemark et al.
Source: Self-asserted source
Jon Stobo

The copy number and mutational landscape of recurrent ovarian high-grade serous carcinoma

Nature Communications
2023-07-20 | Journal article
DOI: 10.1038/s41467-023-39867-7
Part of ISSN: 2041-1723
Contributors: PS Smith; Thomas Bradley; Lena Morrill Gavarró; Teodora Goranova; Darren P. Ennis; Hasan Mirza; Dilrini De Silva; Anna M. Piskorz; Carolin Sauer; Sarwah Al-Khalidi et al.
Source: Self-asserted source
Jon Stobo

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

Leukemia
2020-07 | Journal article
DOI: 10.1038/s41375-019-0700-9
Part of ISSN: 0887-6924
Part of ISSN: 1476-5551
Source: Self-asserted source
Jon Stobo

PARADIGM-2: Two parallel phase I studies of olaparib and radiotherapy or olaparib and radiotherapy plus temozolomide in patients with newly diagnosed glioblastoma, with treatment stratified by MGMT status

Clinical and Translational Radiation Oncology
2018-01 | Journal article
DOI: 10.1016/j.ctro.2017.11.003
Part of ISSN: 2405-6308
Source: Self-asserted source
Jon Stobo
grade
Preferred source (of 2)‎

SYSTEMS-2: A randomised phase II study of radiotherapy dose escalation for pain control in malignant pleural mesothelioma

Clinical and Translational Radiation Oncology
2018-01 | Journal article
DOI: 10.1016/j.ctro.2017.11.004
Part of ISSN: 2405-6308
Source: Self-asserted source
Jon Stobo

Reply to M. Horiguchi et al

Journal of Clinical Oncology
2017-10-10 | Journal article
DOI: 10.1200/jco.2017.74.4292
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Source: Self-asserted source
Jon Stobo

Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer

Journal of Clinical Oncology
2017-06-01 | Journal article
DOI: 10.1200/jco.2016.70.7828
Part of ISSN: 0732-183X
Part of ISSN: 1527-7755
Source: Self-asserted source
Jon Stobo

Safety and utility of image-guided research biopsies in relapsed high-grade serous ovarian carcinoma—experience of the BriTROC consortium

British Journal of Cancer
2017-05-09 | Journal article
DOI: 10.1038/bjc.2017.86
Part of ISSN: 0007-0920
Part of ISSN: 1532-1827
Source: Self-asserted source
Jon Stobo

Pain in Malignant Pleural Mesothelioma: A Prospective Characterization Study

Pain Medicine
2016-11 | Journal article
DOI: 10.1093/pm/pnw061
Part of ISSN: 1526-2375
Part of ISSN: 1526-4637
Source: Self-asserted source
Jon Stobo

Is Radiotherapy Useful for Treating Pain in Mesothelioma?: A Phase II Trial

Journal of Thoracic Oncology
2015-06 | Journal article
DOI: 10.1097/jto.0000000000000499
Part of ISSN: 1556-0864
Source: Self-asserted source
Jon Stobo

F-18 FDG PET-CT Influences Target Delineation When Combined With Standard CT-Based Radiotherapy Planning in the Palliative Setting in Malignant Pleural Mesothelioma; an Exploratory Study

Reports of Radiotherapy and Oncology
2015-06-12 | Journal article
DOI: 10.17795/rro-3999
Part of ISSN: 2345-3192
Part of ISSN: 2345-3176
Source: Self-asserted source
Jon Stobo

Safety and efficacy of pulsed imatinib with or without G-CSFversuscontinuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up

British Journal of Haematology
2013-12 | Journal article
DOI: 10.1111/bjh.12532
Part of ISSN: 0007-1048
Source: Self-asserted source
Jon Stobo

Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex

JNCI: Journal of the National Cancer Institute
2013-03-20 | Journal article
DOI: 10.1093/jnci/djt006
Part of ISSN: 1460-2105
Part of ISSN: 0027-8874
Source: Self-asserted source
Jon Stobo

Peer review (2 reviews for 2 publications/grants)

Review activity for British journal of cancer. (1)
Review activity for Trials (1)
How many people are using ORCID?